Public list: Pharma Startups (6570) Cancer Therapeutics (1180)
Inthera Bioscience, founded in 2013, employs a proprietary technology platform to rationally design protein-protein interaction inhibitors. The company has discovered disruptors of hypoxia-inducible signaling for the treatment of solid tumors and tar...Show all
Company (Alive / Active)
Phone:
Einsiedlerstrasse 34
Waedenswil, 8820
Switzerland
Per Week | Per Month | Per 6 Months | Per Year | |
---|---|---|---|---|
Rank | Login to see details | |||
Page Views Per Million | Login to see details | |||
Page Views Per User | Login to see details | |||
Reach Per Million | Login to see details |
Investor | Investor Type | Location | Participating Rounds |
---|
Title | Application Date | Patent Date | Status (Patent / Application) |
---|---|---|---|
Oxopiperazine derivatives | Dec 17, 2018 | Jul 14, 2020 | Patent |